Clinical researcher Nadine Spring discusses the long-standing lack of diversity in clinical trials and why she's fighting for ...
embracing diversity and inclusion in all aspects of Pharma’s operations, from the top of C-suite executives down to the clinical trial participants and advisory board members, will serve to ...
ORLANDO — Increasing diversity in research, from basic and translational to clinical science, is more important than ever and clinicians need to meet people where they are to do so, according to ...
Black patients were just as eager to participate in research as white patients, and according to Liu, a big reason for lack of diversity in clinical trials is that they are mostly run out research ...
Hosted on MSN2mon
European supergroup launches to tackle diversity in clinical trialsDubbed Research in Europe and Diversity Inclusion ... overcome barriers to clinical study participation, such as lack of information or awareness, mistrust, poor communication, geographic ...
FDA’s ‘mixed signals’ on diversity have entangled clinical trials. Here’s how pharma can push ahead.
The removal of the FDA’s draft guidance on clinical trial diversity from the agency’s website, followed by its reappearance — with a note that the agency and administration “reject” it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results